Safety Shot is a developer of cannabidiol (CBD) based medical therapeutics and wellness products. Co.'s clinical pipeline of prescription CBD-enhanced skin care therapeutics address indications including eczema, burns, herpes cold sores, and skin cancer. Co. is in the early stage of manufacturing, distributing, and marketing a line of consumer products infused with CBD. Co. is developing several formulations to address psoriasis and vitiligo (Photocil), increase the effectiveness of minoxidil to treat hair loss (JW-700 minoxidil booster), women's sexual wellness (JW-500), and jellyfish sting prevention sunscreen (NoStingz), and atopic dermatitis/eczema (JW-110). We show 1 historical shares outstanding datapoints in our coverage of SHOT's shares outstanding history.
Understanding the changing numbers of SHOT shares outstanding — and
comprehending the concept of differing number of shares outstanding in general comparing companies like SHOT versus peers —
is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies.
Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history.
With this page we aim to empower investors researching SHOT by allowing them to research SHOT shares outstanding history
as well as any other stock in our coverage universe. |
Free SHOT Email Alerts:
Video: Shares Outstanding Importance
